headshot of man with arms folded

Anthony Green, PhD

Chief Scientific Officer, Ben Franklin Technology Partners of Southeastern PA

Anthony P. Green, PhD, is Chief Scientific Officer for Ben Franklin Technology Partners of Southeastern PA. Now in his 15th year at Ben Franklin, Dr. Green’s team focuses on Ben Franklin's earliest seed funding program, now representing over $5M in funding to 100 companies and resulting in over $75M in follow-on funding; business and pipeline development for investment opportunities and strategic partnerships; managing its service/prototyping programs and participation in the region’s research institution’s translational research programs. Dr. Green was instrumental in the creation and management of Mentor Connect--a partnership with PACT to bring the MIT Venture Mentoring Service to Philadelphia. Dr. Green also created the Drexel University and Temple University co-investment programs—the first programs of their kind in the country. Dr. Green has helped develop and implement new university/industry partnership/commercialization models for Ben Franklin’s region-wide technology partnerships. Major initiatives in emerging technologies include life sciences/medtech/digital health, advanced textiles, advanced manufacturing, nanotechnology, energy, and IoT, many funded through federal grants.

He is a member of the Oversight/Advisory Committees of many of the region’s translational research programs, including the Coulter-Drexel Translational Research Partnership, Penn Singh Center for Nanotechnology, Children’s Hospital’s Pennsylvania Pediatric Medical Device Consortium and their Innovation Council, and the Temple University Professional Science Master’s Program in Bioinnovation and Biotechnology. He is a Board Observer of Atrin Pharmaceuticals, MBF Therapeutics, and Chromatan. He is also President of the Education Foundation of Lower Merion. Dr. Green has over 30 years of experience in the biotechnology industry focusing on diagnostics and gene transfer technologies. Dr. Green’s track record includes research, development, and commercialization of cutting-edge technologies primarily through small, emerging companies, including Centocor, BD, and Puresyn. Dr. Green earned his Bachelor of Science degree in Immunology, with Honors, from Brown University, in Providence, Rhode Island, and his PhD from Temple University School of Medicine, in Microbiology and Immunology.